Clinical Trials Browser

Phase 2 × tocilizumab × Gastrointestinal × Clear all

NCT02767557 2023-09-22

PACTO

Phase 2 Completed

Gastrointestinal

Unresectable Pancreatic Carcinoma

NCT04258150 2022-03-31

TRIPPLE-R

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms